Matthew B. Frankel

Chief Tech/Sci/R&D Officer at CHEMOMAB THERAPEUTICS LTD.

Net worth: - $ as of 2024-04-29

56 year

Consumer Services

Health Technology

Profile

Matthew B.
Frankel is currently the Chief Medical Officer & VP-Drug Development at Chemomab Therapeutics Ltd.
Prior to this, he worked as the VP-Clinical Development & Medical Affairs at Boehringer Ingelheim Pharmaceuticals, Inc. from 2018 to 2022.
He received his undergraduate degree from Vassar College, his doctorate from David Geffen School of Medicine, and his MBA from Kellogg School of Management.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
CHEMOMAB THERAPEUTICS LTD. -.--%	2024-03-27	0 ( -.--% )	- $	2024-04-29

Matthew B. Frankel active positions

Companies	Position	Start
CHEMOMAB THERAPEUTICS LTD.	Chief Tech/Sci/R&D Officer	2022-11-13

All active positions of Matthew B. Frankel

Former positions of Matthew B. Frankel

Companies	Position	End
Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT.	Chief Tech/Sci/R&D Officer	2022-10-31

See the detail of Matthew B. Frankel's experience

Training of Matthew B. Frankel

Vassar College	Undergraduate Degree
David Geffen School of Medicine	Doctorate Degree
Kellogg School of Management	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Matthew B. Frankel's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
CHEMOMAB THERAPEUTICS LTD.	Health Technology

Private companies	1
Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT.	Health Technology